Shanghai Fosun Pharmaceutical Group Co., Ltd. (08HH)
XSTU
Closed
Aug 24, 2026
Day's Range
1.8152 wk Range
1.66Overview - 08HH - Shanghai Fosun Pharmaceutical Group Co., Ltd.
Key Statistics
Valuation
Enterprise Value
5.55B
P/E (Trailing)
‪11.05‬
Price / Sales (TTM)
‪0.11‬
Price / Book
‪0.79‬
EV / EBITDA
‪7.07‬
Profitability
Gross Margin
‪49.70%‬
Profit Margin
‪8.21%‬
Operating Margin
‪8.07%‬
Return on Assets
‪1.53%‬
Return on Equity
‪7.04%‬
Ownership
Shares Outstanding
2.67B
Float
1.63B
Held by Insiders
‪14.35%‬
Held by Institutions
‪24.29%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪1.79‬
200-Day Avg
‪2.04‬
Dividends
Payout Ratio
‪24.43%‬
Frequency
Annual
Market Cap - 08HH - Shanghai Fosun Pharmaceutical Group Co., Ltd.
Peers - 08HH - Shanghai Fosun Pharmaceutical Group Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XSTU.
Profile Summary - 08HH - Shanghai Fosun Pharmaceutical Group Co., Ltd.
About
Shanghai Fosun Pharmaceutical Group Co., Ltd. is a prominent healthcare enterprise specializing in the research, manufacture, and distribution of pharmaceutical products. The company plays a crucial role in the healthcare and life sciences sector by providing innovative treatments and medical services essential for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
